Aleor

Alembic Pharma JV Aleor Dermaceuticals gets USFDA nod for testosterone topical solution

Alembic Pharma JV Aleor Dermaceuticals gets USFDA nod for testosterone topical solution

Aleor Dermaceuticals has received final approval from the US Food and Drug Administration (USFDA) for its abbreviated new drug application (ANDA) for Testosterone Topical Solution USP, 30 mg per pump actuation, Alembic Pharmaceuticals said in a regulatory filing. Aleor Dermaceuticals has received final approval from the US Food and Drug Administration (USFDA) for its abbreviated new drug application (ANDA) for Testosterone Topical Solution USP, 30 mg per pump actuation, Alembic Pharmaceuticals said in a regulatory filing. Testosterone Topical Solution actuation is indicated for replacement therapy in males for conditions…
Read More
No widgets found. Go to Widget page and add the widget in Offcanvas Sidebar Widget Area.